PIGR and neoplasm: Of the 13 validated differentially expressed genes, 7 and 6 were consistently identified by both technologies as significantly more highly expressed in the P5.1/PIGR+ or P5.2/PTGS1+ tumour subclones, respectively (Fig. 4d, Supplementary Data 8).